Profilo
Attualmente, Craig Paterson è Chief Medical Officer alla Allakos, Inc. In passato è stato Chief Medical Officer alla Endo International Plc e Senior VP-Medical & Clinical Development alla Salix Pharmaceuticals Ltd. Si è laureato alla McMaster University e ha conseguito un MBA alla University of Tennessee.
Precedenti posizioni note di Craig Paterson
| Società | Posizione | Fine |
|---|---|---|
| ALLAKOS INC. | Direttore Tecnico/Scientifico/R&S | 09/02/2024 |
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Vivelix Pharmaceuticalsc Corp. | Fondatore | - |
| ENDO INTERNATIONAL PLC | Direttore Tecnico/Scientifico/R&S | - |
| SALIX PHARMACEUTICALS, LTD. | Corporate Officer/Principal | - |
Formazione di Craig Paterson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Salix Pharmaceuticals Ltd.
Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops prescription drugs | Health Technology |
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tennessee
University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allakos, Inc.
Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases | Health Technology |
Vivelix Pharmaceuticalsc Corp. |
















